These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 27887589)

  • 1. Guidelines for dementia or Parkinson's disease with depression or anxiety: a systematic review.
    Goodarzi Z; Mele B; Guo S; Hanson H; Jette N; Patten S; Pringsheim T; Holroyd-Leduc J
    BMC Neurol; 2016 Nov; 16(1):244. PubMed ID: 27887589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers and Facilitators for Guidelines with Depression and Anxiety in Parkinson's Disease or Dementia.
    Goodarzi Z; Hanson HM; Jette N; Patten S; Pringsheim T; Holroyd-Leduc J
    Can J Aging; 2018 Jun; 37(2):185-199. PubMed ID: 29618389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical practice guideline recommendations for diagnosis and management of anxiety and depression in hospitalized adults with delirium: a systematic review.
    Poulin TG; Jaworska N; Stelfox HT; Fiest KM; Moss SJ
    Syst Rev; 2023 Sep; 12(1):174. PubMed ID: 37749654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guideline Recommendations on Behavioral and Psychological Symptoms of Dementia: A Systematic Review.
    Watt JA; Porter J; Tavilsup P; Chowdhury M; Hatch S; Ismail Z; Kumar S; Kirkham J; Goodarzi Z; Seitz D
    J Am Med Dir Assoc; 2024 May; 25(5):837-846.e21. PubMed ID: 38640961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive training interventions for dementia and mild cognitive impairment in Parkinson's disease.
    Orgeta V; McDonald KR; Poliakoff E; Hindle JV; Clare L; Leroi I
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD011961. PubMed ID: 32101639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive Behaviour Therapy for Depression and Anxiety in Parkinson's Disease.
    Egan SJ; Laidlaw K; Starkstein S
    J Parkinsons Dis; 2015; 5(3):443-51. PubMed ID: 26406124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary and alternative medicine recommendations for depression: a systematic review and assessment of clinical practice guidelines.
    Ng JY; Nazir Z; Nault H
    BMC Complement Med Ther; 2020 Oct; 20(1):299. PubMed ID: 33028320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive behavioral therapy for depression and anxiety of Parkinson's disease: A systematic review and meta-analysis.
    Zhang Q; Yang X; Song H; Jin Y
    Complement Ther Clin Pract; 2020 May; 39():101111. PubMed ID: 32379650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal Treatment of Depression and Anxiety in Parkinson's Disease.
    Pontone GM; Mills KA
    Am J Geriatr Psychiatry; 2021 Jun; 29(6):530-540. PubMed ID: 33648830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practice Parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
    Miyasaki JM; Shannon K; Voon V; Ravina B; Kleiner-Fisman G; Anderson K; Shulman LM; Gronseth G; Weiner WJ;
    Neurology; 2006 Apr; 66(7):996-1002. PubMed ID: 16606910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An appraisal of the trustworthiness of practice guidelines for depression and anxiety in children and youth.
    Bennett K; Courtney D; Duda S; Henderson J; Szatmari P
    Depress Anxiety; 2018 Jun; 35(6):530-540. PubMed ID: 29697887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosocial interventions for depression and anxiety in Parkinson's disease.
    Yang S; Sajatovic M; Walter BL
    J Geriatr Psychiatry Neurol; 2012 Jun; 25(2):113-21. PubMed ID: 22689704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Nonmotor Symptoms in Parkinson's Disease.
    Sauerbier A; Cova I; Rosa-Grilo M; Taddei RN; Mischley LK; Chaudhuri KR
    Int Rev Neurobiol; 2017; 132():361-379. PubMed ID: 28554415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
    Rolinski M; Fox C; Maidment I; McShane R
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and treatment of dementia: 5. Nonpharmacologic and pharmacologic therapy for mild to moderate dementia.
    Hogan DB; Bailey P; Black S; Carswell A; Chertkow H; Clarke B; Cohen C; Fisk JD; Forbes D; Man-Son-Hing M; Lanctôt K; Morgan D; Thorpe L
    CMAJ; 2008 Nov; 179(10):1019-26. PubMed ID: 18981443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methodological quality of clinical practice guidelines with physical activity recommendations for people diagnosed with cancer: A systematic critical appraisal using the AGREE II tool.
    Shallwani SM; King J; Thomas R; Thevenot O; De Angelis G; Aburub AS; Brosseau L
    PLoS One; 2019; 14(4):e0214846. PubMed ID: 30969981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of depression and anxiety via patient-assessed tremor severity, not physician-reported motor symptom severity, in patients with Parkinson's disease or essential tremor who have undergone deep brain stimulation.
    Achey RL; Yamamoto E; Sexton D; Hammer C; Lee BS; Butler RS; Thompson NR; Nagel SJ; Machado AG; Lobel DA
    J Neurosurg; 2018 Dec; 129(6):1562-1571. PubMed ID: 29473781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis of randomised placebo-controlled treatment trials for depression and anxiety in Parkinson's disease.
    Troeung L; Egan SJ; Gasson N
    PLoS One; 2013; 8(11):e79510. PubMed ID: 24236141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.